v3.25.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Series Seed convertible preferred stock
Series A convertible preferred stock
Series B convertible preferred stock
Series C convertible preferred stock
Total
Balance at beginning at Dec. 31, 2023         $ 956 $ 55,840 $ 193,290    
Balance at beginning (in shares) at Dec. 31, 2023         1,785,714 17,589,380 81,242,587    
Balance at end at Mar. 31, 2024         $ 956 $ 55,840 $ 193,290    
Balance at the end (in shares) at Mar. 31, 2024         1,785,714 17,589,380 81,242,587    
Balance at the beginning at Dec. 31, 2023   $ 4,645 $ 37 $ (230,403)         $ (225,721)
Balance at beginning (in shares) at Dec. 31, 2023 1,576,854                
Changes in Stockholders' Equity (Deficit)                  
Repurchase of unvested restricted stock awards (in shares) (21,172)                
Exercises of common stock options   42             42
Exercises of common stock options (in shares) 7,035                
Stock-based compensation expense   947             947
Foreign currency translation adjustment     37           37
Net Income (Loss)       (27,800)         (27,800)
Balance at end at Mar. 31, 2024   5,634 74 (258,203)         (252,495)
Balance at end (in shares) at Mar. 31, 2024 1,562,717                
Balance at beginning at Dec. 31, 2023         $ 956 $ 55,840 $ 193,290    
Balance at beginning (in shares) at Dec. 31, 2023         1,785,714 17,589,380 81,242,587    
Balance at end at Jun. 30, 2024         $ 956 $ 55,840 $ 193,290 $ 199,526  
Balance at the end (in shares) at Jun. 30, 2024         1,785,714 17,589,380 81,242,587 116,275,239  
Balance at the beginning at Dec. 31, 2023   4,645 37 (230,403)         (225,721)
Balance at beginning (in shares) at Dec. 31, 2023 1,576,854                
Changes in Stockholders' Equity (Deficit)                  
Foreign currency translation adjustment                 67
Net Income (Loss)                 (65,777)
Balance at end at Jun. 30, 2024   7,294 104 (296,180)         (288,782)
Balance at end (in shares) at Jun. 30, 2024 1,578,372                
Balance at beginning at Mar. 31, 2024         $ 956 $ 55,840 $ 193,290    
Balance at beginning (in shares) at Mar. 31, 2024         1,785,714 17,589,380 81,242,587    
Changes in Convertible Preferred Stock                  
Issuance of convertible preferred stock               $ 199,526  
Issuance of convertible preferred stock (in shares)               116,275,239  
Balance at end at Jun. 30, 2024         $ 956 $ 55,840 $ 193,290 $ 199,526  
Balance at the end (in shares) at Jun. 30, 2024         1,785,714 17,589,380 81,242,587 116,275,239  
Balance at the beginning at Mar. 31, 2024   5,634 74 (258,203)         (252,495)
Balance at beginning (in shares) at Mar. 31, 2024 1,562,717                
Changes in Stockholders' Equity (Deficit)                  
Exercises of common stock options   124             124
Exercises of common stock options (in shares) 15,655                
Stock-based compensation expense   1,536             1,536
Foreign currency translation adjustment     30           30
Net Income (Loss)       (37,977)         (37,977)
Balance at end at Jun. 30, 2024   7,294 104 (296,180)         (288,782)
Balance at end (in shares) at Jun. 30, 2024 1,578,372                
Balance at the beginning at Dec. 31, 2024 $ 4 699,651 194 (387,391)         312,458
Balance at beginning (in shares) at Dec. 31, 2024 41,793,412                
Changes in Stockholders' Equity (Deficit)                  
Exercises of common stock options   99             99
Exercises of common stock options (in shares) 28,475                
Stock-based compensation expense   5,386             5,386
Unrealized gain on investments     12           12
Foreign currency translation adjustment     (65)           (65)
Net Income (Loss)       (33,573)         (33,573)
Balance at end at Mar. 31, 2025 $ 4 705,136 141 (420,964)         284,317
Balance at end (in shares) at Mar. 31, 2025 41,821,887                
Balance at the beginning at Dec. 31, 2024 $ 4 699,651 194 (387,391)         $ 312,458
Balance at beginning (in shares) at Dec. 31, 2024 41,793,412                
Changes in Stockholders' Equity (Deficit)                  
Exercises of common stock options (in shares)                 295,285
Unrealized gain on investments                 $ 42
Foreign currency translation adjustment                 (330)
Net Income (Loss)                 (85,796)
Balance at end at Jun. 30, 2025 $ 4 712,903 (94) (473,187)         239,626
Balance at end (in shares) at Jun. 30, 2025 42,088,697                
Balance at the beginning at Mar. 31, 2025 $ 4 705,136 141 (420,964)         284,317
Balance at beginning (in shares) at Mar. 31, 2025 41,821,887                
Changes in Stockholders' Equity (Deficit)                  
Exercises of common stock options   1,722             1,722
Exercises of common stock options (in shares) 266,810                
Stock-based compensation expense   6,045             6,045
Unrealized gain on investments     30           30
Foreign currency translation adjustment     (265)           (265)
Net Income (Loss)       (52,223)         (52,223)
Balance at end at Jun. 30, 2025 $ 4 $ 712,903 $ (94) $ (473,187)         $ 239,626
Balance at end (in shares) at Jun. 30, 2025 42,088,697